• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

pkhaw@unimelb.edu.au

Credentials


Position
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-1474-0881

A/Prof Pearly Khaw

Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology

59 Scholarly works
2 Projects

HIGHLIGHTS

  • 2026

    Journal article

    No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinoma
    DOI: 10.1016/j.ejca.2026.116885
  • 2026

    Journal article

    Assessing predictors of brachytherapy utilization among cervical cancer patients in Nigeria: evidence from a tertiary cancer centre.
    DOI: 10.1186/s12885-026-16311-9
  • 2026

    Journal article

    POLARIX: POLE-mutation analysis by rapid image-based screening in endometrial cancer
    DOI: 10.1016/j.ijgc.2025.104436
  • 2026

    Journal article

    Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapy
    DOI: 10.1016/j.ijgc.2025.102874
  • 2025

    Journal article

    Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
    DOI: 10.1097/OGX.0000000000001475
  • 2024

    Research grants (other domestic)

    Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Adjuvant Tislelizumab Plus Chemotherapy After Post-Operative Pelvic Chemoradiation in High Risk Endometrial Cancer: The ADELE Study
Pearly Khaw

Latest Honours,
Awards and Fellowships


2001
Fellow of the Royal Australian and New Zealand College of Radiology (FRANZCR)

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
    DOI: 10.1016/S1470-2045(25)00379-1
  • 2025

    Conference Proceedings

    1172P The relationship between patient-reported outcomes and clinician-rated toxicity in participants with locally advanced cervix cancer in the OUTBACK trial
    DOI: 10.1016/j.annonc.2025.08.1808
  • 2025

    Journal article

    Node-positive carcinoma of the vulva treated with curative-intent radiotherapy
    DOI: 10.1016/j.ijgc.2025.101916
  • 2025

    Journal article

    Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates
    DOI: 10.1016/j.modpat.2024.100660
  • 2024

    Journal article

    Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup
    DOI: 10.1016/S1470-2045(24)00192-X

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224